CUEDC2 Contributes to Cisplatin-Based Chemotherapy Resistance in Ovarian Serious Carcinoma by Regulating p38 MAPK Signaling

Chemoresistance remains an obstacle to the successful treatment of ovarian carcinoma. CUE domain-containing 2 (CUEDC2) plays critical roles in tumor genesis and overexpresses in many solid cancers, including ovarian serous carcinoma. In previous study, we found that overexpression of CUEDC2 might be...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Aichun, Li, Jinhang, Zhou, Tao, Li, Tao, Cai, Hong, Shi, Huaiyin, Liu, Aijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547988/
https://www.ncbi.nlm.nih.gov/pubmed/31205536
http://dx.doi.org/10.7150/jca.29889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547988/
https://www.ncbi.nlm.nih.gov/pubmed/31205536
http://dx.doi.org/10.7150/jca.29889

Ejemplares similares